Dr. John Abrahams treats disorders of the brain and spine as BSSNY President. He is the author of numerous patents, has authored over 30 publications in peer-reviewed journals and textbooks, and given lectures at many national and local meetings. In addition to being BSSNY President, he is also Northern Westchester Hospital’s Co-Director of the Spine Section of the Orthopedic and Spine Institute. In 2009, he founded and now runs the Westchester Neuroscience Research Foundation. The Foundation is currently funding a project in conjunction with the Department of Pathology at New York Medical College studying the genomic profile of malignant brain tumors.
Dr. Abrahams has a background in biomedical engineering and been quite active as a biomedical entrepreneur, and has founded numerous biomedical companies including EndoMedix, AsiloMedix, Connectiphi, and Osteomedix. Dr. Abrahams’ most recent project is a surgical robotic device for brain surgery.
Dr. Abrahams was named President of Brain & Spine Surgeons of New York in 2015 and was recently named one of the “Top 10 Spine, Orthopedic Surgeon Tech Entrepreneurs to Know” by Becker’s Spine Review.
Northern Westchester Hospital, Chief of Neurosurgery, Mt. Kisco, New York
Westchester Medical Center, Valhalla, New York
White Plains Hospital, White Plains, New York
Dr. Abrahams and his Research Team launched their Best Practices for Spine Surgery in 2021. Through this program, they have lowered cost in spine surgery while improving outcome with functional data in their patients.
Dr. Abrahams developed a software tracking tool that helps he and his team follow up on patients after surgery. The tool automates responses through text messaging and now can replace an in-person visit with Remote Therapeutic Monitoring (RTM).
Dr. Abrahams and research team retrospectively reviewed all spine patients over an 8 year period to develop trends in care, complication profiles, and outcome data. The study involved almost 4,000 patients and lead to the publication of multiple peer-reviewed abstracts.
Dr. Abrahams developed hemostatic sealant to be used in Brain Surgery. The Company (www.endomedix.com) was founded over 10 years ago and based in Montvale, NJ. The Company has received over $5 M in funding and has a number of patents related to their technology.
Dr. Abrahams developed a bone dust collector (www.capseus.com) to use a patient’s bone during surgery rather than cadaver bone. He has been using the device for years with excellent results. The company now has a national sales force and developing other products to help in spine surgery.
DTX Medical, Inc.
Dr. Abrahams developed DTX (www.dtxmed.com) as a Software as a Medical Device (SaMD) to obtain patient reported outcomes (PROs) and engage patients and providers through Remote Therapeutic Monitoring (RTM). RTM allows providers to obtain patient information and reduces costs by reducing outpatient visit expense.
Dr. Abrahams created a seamless after hours call software program called OnCallX (oncallx.com) that eliminates the need for an operator; allows patients to contact their provider any time with immediate response and above, reduce the cost of the service.
In 2016, Dr. Abrahams began to develop a Neurosurgical Robot to aid in surgical procedures. He teamed up with Honeybee Robotics, a leader in lunar exploration vehicles and tools, and developed a prototype Smart Retractor. A patent was filed in 2019 (62/790,843 – Smart Robot-Assisted Brain & Spine Surgical System). Dr. Abrahams continues to develop and is in the process of submitting a government